Indivior PLC (LON:INDV – Get Free Report) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 1,238 ($16.69) and traded as low as GBX 1,230 ($16.58). Indivior shares last traded at GBX 1,238 ($16.69), with a volume of 8,457,898 shares changing hands.
Indivior Stock Performance
The firm has a market cap of £1.93 billion, a PE ratio of -1,026.48, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52. The company has a 50 day simple moving average of GBX 1,238 and a 200-day simple moving average of GBX 1,029.73.
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Recommended Stories
- Five stocks we like better than Indivior
- Expert Stock Trading Psychology Tips
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- ETF Screener: Uses and Step-by-Step Guide
- 3 Exceptional Stocks to Build Long-Term Wealth
- How to Invest in the FAANG Stocks
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.